negative binomial regression model with random effects stata 8.1 Search Results


vero cells  (ATCC)
99
ATCC vero cells
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Vero Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vero cells/product/ATCC
Average 99 stars, based on 1 article reviews
vero cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
tween 20  (Thermo Fisher)
99
Thermo Fisher tween 20
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Tween 20, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tween 20/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
tween 20 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
es cell characterization kit  (Millipore)
90
Millipore es cell characterization kit
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Es Cell Characterization Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/es cell characterization kit/product/Millipore
Average 90 stars, based on 1 article reviews
es cell characterization kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
tween 20  (New England Biolabs)
86
New England Biolabs tween 20
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Tween 20, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tween 20/product/New England Biolabs
Average 86 stars, based on 1 article reviews
tween 20 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
anti vegfr2  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc anti vegfr2
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Anti Vegfr2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti vegfr2/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
anti vegfr2 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
tween 20  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology tween 20
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Tween 20, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tween 20/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
tween 20 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
ultrasonic bath cole parmer 8850  (Cole-Parmer)
86
Cole-Parmer ultrasonic bath cole parmer 8850
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Ultrasonic Bath Cole Parmer 8850, supplied by Cole-Parmer, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ultrasonic bath cole parmer 8850/product/Cole-Parmer
Average 86 stars, based on 1 article reviews
ultrasonic bath cole parmer 8850 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
tbst  (Millipore)
90
Millipore tbst
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Tbst, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tbst/product/Millipore
Average 90 stars, based on 1 article reviews
tbst - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pcr rflp  (New England Biolabs)
96
New England Biolabs pcr rflp
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Pcr Rflp, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcr rflp/product/New England Biolabs
Average 96 stars, based on 1 article reviews
pcr rflp - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
tween 20  (Millipore)
90
Millipore tween 20
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Tween 20, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tween 20/product/Millipore
Average 90 stars, based on 1 article reviews
tween 20 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
saline tween 20  (New England Biolabs)
96
New England Biolabs saline tween 20
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Saline Tween 20, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/saline tween 20/product/New England Biolabs
Average 96 stars, based on 1 article reviews
saline tween 20 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
pbst  (Bio-Rad)
98
Bio-Rad pbst
Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with <t>Vero</t> <t>cells</t> for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.
Pbst, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbst/product/Bio-Rad
Average 98 stars, based on 1 article reviews
pbst - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

Image Search Results


Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with Vero cells for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.

Journal: Frontiers in Microbiology

Article Title: A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease

doi: 10.3389/fmicb.2017.02115

Figure Lengend Snippet: Reduced frequency of HSV reactivations from the trigeminal ganglia of antibody-treated mice. Mice ( n = 10) were infected with HSV-1 KOS. The antibodies mAb 2c or mAb hu2c were applied at 24 h prior to infection (pre-exposure prophylaxis, P), at 24, 40, and 56 h after infection (PEP) or at day 6 post-infection (therapy, T, only mAb 2c). Topical treatment with mAb 2c was started at 24 h post-infection and performed five times per day by applying antibody containing eye drops until day 12. ACV standard therapy at 10 mg/kg body weight was performed three times a day by intraperitoneal injection. The percentages of reactivating ipsilateral or contralateral trigeminal ganglia from HSV-1 KOS-infected mice are shown. Trigeminal ganglia were isolated on day 12 after infection and co-cultured with Vero cells for 4 weeks. The occurrence of cytopathic effects was equated as reactivation. The differences in the total numbers of reactivating ganglia between the antibody treatment groups were compared with PBS and statistical significances were determined with the Fisher’s exact test. Comparisons were considered significant at ∗ P < 0.05; ∗∗ P < 0.01; and ∗∗∗ P < 0.001.

Article Snippet: Vero cells (American Type Culture Collection, ATCC, CCL81, Rockville, MD, United States) were cultured in Dulbecco’s Modified Eagle Medium (DMEM; Life Technologies Gibco, Darmstadt, Germany) containing 10% (v/v) FCS (Life Technologies Gibco), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (penicillin–streptomycin).

Techniques: Infection, Eye Drops, Injection, Isolation, Cell Culture